Mrazek David A
Department of Psychiatry and Psychology, Mayo Clinic, USA.
Minn Med. 2007 Jan;90(1):42-3.
Pharmacogenetic testing allows physicians to identify patients who are likely to have adverse reactions to certain medications because they metabolize them poorly or too rapidly. Much research has focused on the gene P-450 2D6, which has been shown to affect patients' response to various drugs including antidepressants and antipsychotics. Patients with certain genotypes may experience negative side effects from medications or may see no benefit at all. This article describes the first pharmacogenetic test to be widely used, which identifies variation in the P-450 2D6 gene, and the patient populations that would benefit from it.
药物遗传学检测使医生能够识别出那些可能对某些药物产生不良反应的患者,因为他们对这些药物的代谢能力较差或过快。许多研究都集中在P-450 2D6基因上,该基因已被证明会影响患者对包括抗抑郁药和抗精神病药在内的各种药物的反应。具有某些基因型的患者可能会经历药物的负面副作用,或者可能根本看不到任何益处。本文介绍了首个被广泛使用的药物遗传学检测,该检测可识别P-450 2D6基因的变异情况,以及将从中受益的患者群体。